GALECTIN THERAPEUTICS INC 4
4 · GALECTIN THERAPEUTICS INC · Filed Oct 3, 2013
Insider Transaction Report
Form 4
MAULDIN JOHN F
Director
Transactions
- Purchase
Common Stock
2013-10-02$9.97/sh+125$1,246→ 16,369 total - Purchase
Common Stock
2013-10-01$9.96/sh+376$3,746→ 16,244 total
Holdings
- 4,947(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2013.
- [F2]Reflects weighted average price. Range of prices were between $9.95 and $9.97. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.